摘要
Aberrant histone methylation is a frequent event during tumor development and progression. KMT1E (also known as SETDB1) is a histone H3K9 methyltransferase that contributes to epigenetic silencing of both oncogenes and tumor suppressor genes in cancer cells. In this report, we demonstrate that KMT1E acts as a metastasis suppressor that is strongly downregulated in highly metastatic lung cancer cells. Restoring KMT1E expression in this setting suppressed filopodia formation, migration, and invasive behavior. Conversely, loss of KMT1E in lung cancer cells with limited metastatic potential promoted migration in vitro and restored metastatic prowess in vivo. Mechanistic investigations indicated that KMT1E cooperates with the TGFβ-regulated complex SMAD2/3 to repress metastasis through ANXA2. Together, our findings defined an essential role for the KMT1E/SMAD2/3 repressor complex in TGFβ-mediated lung cancer metastasis.
| 原文 | 英語 |
|---|---|
| 頁(從 - 到) | 7333-7343 |
| 頁數 | 11 |
| 期刊 | Cancer Research |
| 卷 | 74 |
| 發行號 | 24 |
| DOIs | |
| 出版品狀態 | 已發佈 - 12月 15 2014 |
| 對外發佈 | 是 |
UN SDG
此研究成果有助於以下永續發展目標
-
SDG 3 良好的健康和福祉
ASJC Scopus subject areas
- 腫瘤科
- 癌症研究
指紋
深入研究「H3K9 histone methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis」主題。共同形成了獨特的指紋。引用此
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS